Colorectal Cancer Clinical Trial
— DIGEROfficial title:
Impact of a Multidisciplinary Approach in the Perioperative Geriatrics Unit on Functional Status of Patients Aged 70 and Over Operated on for Colorectal Cancer. Randomized Open-label Controlled Study
Health establishments encourage the development of specific care pathways for the elderly by supporting Geriatric Peri-Operative Units (GPOU). Indeed, this shared care model has shown a clear reduction in mortality and the number of re-hospitalizations in patients 6 months after their care. The multidisciplinary approach of global management of the patient in the perioperative period aims to reduce surgical stress as well as the rapid restoration of previous physical and psychic abilities. Colorectal surgery, the main treatment for stage I to III colon cancer, is a morbid surgery. Despite numerous efficacy data on improved rehabilitation after colorectal surgery, care programs are not specific to the geriatric population and geriatric assessment criteria to describe the functional status of patients are not commonly used. The study investigators wish to evaluate the impact of GPOU treatment following colorectal surgery, on the evolution of several clinical parameters such as: functional status, morbidity mortality, quality of life, and lifestyle. The study investigators hypothesize that management in the GPOU for colorectal cancer surgery in patients aged 70 and over will improve functional status at 3 months, in comparison with traditional management. The proposed intervention should also lead to an improvement in patient satisfaction with care, complications and re-hospitalizations, nutritional status, lifestyle and patient survival.
Status | Not yet recruiting |
Enrollment | 90 |
Est. completion date | October 2025 |
Est. primary completion date | October 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 70 Years and older |
Eligibility | Inclusion Criteria: - The patient or their representative must have given their free and informed consent and signed the consent form - The patient must be a member or beneficiary of a health insurance plan - Diagnosis of proven colorectal cancer. - Patient to benefit from scheduled colorectal surgery at the University Hospital of Nîmes validated in digestive surgery SPC after oncogeriatric evaluation. - Surgical act: resection with anastomosis in one step. Exclusion Criteria: - The subject is participating in a category 1 interventional study, or is in a period of exclusion determined by a previous study - It is impossible to give the subject informed information - The patient is under safeguard of justice or state guardianship |
Country | Name | City | State |
---|---|---|---|
France | CHU de Nîmes | Nimes |
Lead Sponsor | Collaborator |
---|---|
Centre Hospitalier Universitaire de Nimes |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in functional status after colorectal cancer surgery between groups | Instrumental Activities of Daily Living (IADL) score (score 0-8) | Baseline and Month 3 | |
Secondary | Change in functional status between groups | Instrumental Activities of Daily Living (IADL) score (score 0-8) | Baseline and Month 6 | |
Secondary | Change in basic functional status between groups | Katz index of independence in Activities of Daily Living scale (ADL) (score 0-6) | Baseline, hospital discharge (an average of 10 days), Month 3, and Month 6 | |
Secondary | Change in patient motor ability between groups | Time Up and Go test (Score 0-3 for each item, time in seconds) | Baseline, Month 3 | |
Secondary | Patient satisfaction with care between groups | EORTC SATisfaction with IN-PATient cancer care (IN-PATSAT) 32 questionnaire (Score 32-160) | Hospital discharge (an average of 10 days) | |
Secondary | Length of hospital stay between groups | Days | Hospital discharge (an average of 10 days) | |
Secondary | The number of medical complications during hospitalization between groups | Number of following events: diabetes decompensation, cardiorespiratory decompensation, pulmonary and urinary infections, acute renal failure, anemia. Aggravation of: confusion, pelvic exoneration disorders, fall, bedsores. | Hospital discharge (an average of 10 days) | |
Secondary | The distribution of surgical complications between groups | Gravity of surgical complications according to the Clavien Dindo classification | Hospital discharge (an average of 10 days) | |
Secondary | The distribution of surgical complications between groups | Gravity of surgical complications according to the Clavien Dindo classification | Month 1 | |
Secondary | Destination of patients on discharge from hospital between groups | Classified as: home / nursing home or institutionalization / transfer to Aftercare and Rehabilitation / transfer to another service / none (death during hospitalization). | Hospital discharge (an average of 10 days) | |
Secondary | The change in the patient's weight between groups | Percent change in Kg | Baseline and Month 3 | |
Secondary | Patient quality of life between groups | EORTC-QLQ-C30 questionnaire score (Score 0-100) | Month 3 | |
Secondary | Patient quality of life between groups | EORTC-QLQ-C30 questionnaire score (Score 0-100) | Month 6 | |
Secondary | Change in the patient's place of abode between groups | Rate (%) of patients living at home/in nursing home/residential home | Month 1, Month 3 and Month 6 | |
Secondary | Overall survival between groups. | Percentage of immediate mortality (during the hospital stay) | Month 1 | |
Secondary | Overall survival between groups. | Percentage of immediate mortality (during the hospital stay) | Month 3 | |
Secondary | Overall survival between groups. | Percentage of immediate mortality (during the hospital stay) | Month 6 | |
Secondary | The rate of early unscheduled re-hospitalizations or admissions to the emergency department between groups | Re-hospitalization in the month following discharge from hospital: yes/no. | Month 1 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05400122 -
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
|
Phase 1 | |
Active, not recruiting |
NCT05551052 -
CRC Detection Reliable Assessment With Blood
|
||
Completed |
NCT00098787 -
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
|
Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT05425940 -
Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer
|
Phase 3 | |
Suspended |
NCT04595604 -
Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery.
|
N/A | |
Completed |
NCT03414125 -
Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer Screening
|
N/A | |
Completed |
NCT02963831 -
A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies
|
Phase 1/Phase 2 | |
Recruiting |
NCT05489211 -
Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
|
Phase 2 | |
Terminated |
NCT01847599 -
Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib
|
N/A | |
Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
Recruiting |
NCT03874026 -
Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients
|
Phase 2 | |
Active, not recruiting |
NCT03170960 -
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
Completed |
NCT03167125 -
Participatory Research to Advance Colon Cancer Prevention
|
N/A | |
Completed |
NCT03181334 -
The C-SPAN Coalition: Colorectal Cancer Screening and Patient Navigation
|
N/A | |
Recruiting |
NCT04258137 -
Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study
|
N/A | |
Recruiting |
NCT05568420 -
A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
|
||
Recruiting |
NCT02972541 -
Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer
|
N/A | |
Completed |
NCT02876224 -
Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors
|
Phase 1 | |
Completed |
NCT01943500 -
Collection of Blood Specimens for Circulating Tumor Cell Analysis
|
N/A |